期刊文献+

医院多重耐药菌血流感染相关因素Logistic回归分析 被引量:9

Logistic regression analysis of related factors of bloodstream infection of multidrug resistant organism in hospital
原文传递
导出
摘要 目的探讨医院多重耐药菌(MDRO)血流感染特点与相关因素,为临床提供依据。方法回顾2014年1月-2018年5月487例医院血流感染患者临床资料,采用SPSS 19. 0软件进行统计分析。结果医院MDRO血流感染率为19. 71%;单因素分析得知患者糖尿病史、感染前住院时间≥7 d、入住ICU、APACHEⅡ评分≥20、手术治疗、深静脉置管、机械通气、留置导尿、使用糖皮质激素、抗菌药物使用时间≥7 d、抗菌药物种数≥3种、联用抗菌药物≥3种、血糖>11. 1 mmol/L、血清白蛋白<30 g/L等14个因素是医院MDRO血流感染的危险因素(P <0. 05);多因素分析得知患者入住ICU、机械通气、深静脉置管、留置导尿、联用抗菌药物≥3种、抗菌药物使用时间≥7 d等6个因素是医院MDRO血流感染的独立危险因素(P <0. 05)。结论正确合理使用抗菌药物,减少不必要的侵入性诊疗操作,缩短入住ICU时间,加强ICU医院MDRO防控是降低医院MDRO血流感染的主要措施。 Objective To investigate the characteristics and related factors of bloodstream infection of multidrug resistant organism(MDRO)in hospital and provide evidence for clinical practice.Methods The clinical data of 487 patients with nosocomial bloodstream infection from January 2014 to May 2018 were retrospectively analyzed by SPSS 19.0 software package.Results The bloodstream infection rate of MDRO in hospital was 19.71%.Univariate analysis showed that 14 factors such as the history of diabetes mellitus,hospitalization time before infection≥7 d,ICU admission,APACHE II score≥20,surgical treatment,deep venous catheterization,mechanical ventilation,indwelling catheterization,use of glucocorticoids,duration of use of antibiotics≥7 d,number of antibiotics≥3,combined use of antibiotics≥3,blood glucose>11.1 mmol/L and serum albumin<30 g/L were risk factors for MDRO bloodstream infection in hospital(P<0.05).Multivariate analysis showed that 6 factors such as ICU admission,mechanical ventilation,deep venous catheterization,indwelling catheterization,combined use of antibiotics≥3 and duration of use of antibiotics≥7 d were independent risk factors for MDRO bloodstream infection in hospital(P<0.05).Conclusion Correct and rational use of antibiotics,reduction of unnecessary invasive diagnosis and treatment operations,shortening of ICU admission time,and strengthening the prevention and control of MDRO in hospital ICU are the main measures to reduce hospital MDRO bloodstream infection.
作者 谢朝云 蒙桂鸾 熊芸 杨忠玲 杨怀 XIE Zhao-yun;MENG Gui-luan;XIONG Yun;YANG Zhong-ling;YANG Huai(The Third Affiliated Hospital of Guizhou Medical University,Duyun Guizhou 558000;Guizhou People's Hospital,China)
出处 《中国消毒学杂志》 CAS 2019年第8期606-608,612,共4页 Chinese Journal of Disinfection
基金 贵州省科技厅联合项目(黔科合LH字〔2014〕7162号) 贵州省黔南州社会发展科技项目(黔南科合社字〔2013〕20号)
关键词 医院感染 血流感染 多重耐药菌 因素分析 nosocomial infection bloodstream infection multidrug resistant organism factor analysis
  • 相关文献

参考文献9

二级参考文献54

  • 1Magiorakos A P,Srinivasan A,Carey R B. Multidrug-resistant,extensively drug-resistant and pandrug-resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance[J].{H}Clinical Microbiology and Infection,2012,(3):268-281.
  • 2Almagro P,Cabrera FJ,Diez J,et al. Comorbidities and short-termprognosis in patients hospitalized for acute exacerbation of COPD:the EPOC en Servicios de medicine interna(ESMI) study[J].Chest,2012,142(5):1126-1133. doi:10.1378/chest.11-2413.
  • 3Magiorakos AP,Srinivasan A,Carey RB,et al. Multidrug-resistamt,extemsively drug- resistant and pandrug- resistant bacteria:aninternational expert proposal for in terim standard definitions foracquired resistance[J].Clin Microbiol Infect,2012,18(3):268-281. doi:10.1111/j.1469-0691.2011.03570.x.
  • 4Domenech A,Puig C,Martí S,et al. Infectious etiology of acuteexacerbations in severe COPD patients[J]. J Infect,2013,67(6):516-523. doi:10.1016/j.jinf.2013.09.003.
  • 5Lee SJ,Lee SH,Kim YE,et al. Clinical features according to thefrequency of acute exacerbation in COPD[J]. Tuberc Respir Dis(Seoul),2012,72(4):367-373. doi:10.4046/trd.2012.72.4.367.
  • 6Eisner MD,Anthonisen N,Coultas D,et al. An official AmericanThoracic Society public policy statement:Novel risk factors and theglobal burden of chronic obstructive pulmonary disease[J]. Am JRespir Crit Care Med,2010,182(5):693- 718. doi:10.1164/rccm.200811-1757ST.
  • 7Leuppi JD,Schuetz P,Bingisser R,et al. Short-term vs conventionalglucocorticoid therapy in acute exacerbations of chronic obstructivepulmonary disease:the REDUCE randomized clinical trial[J]. JAMA,2013,309(21):2223-2231. doi:10.1001/jama.2013.5023.
  • 8Klapdor B,Ewig S. Antimicrobial treatment of patients with severeacute exacerbation of COPD[J]. Med Klin Intensivmed Notfmed,2012,107(3):179-184. doi:10.1007/s00063-011-0066-x.
  • 9Munoz-Price LS,Weinstein RA.Acinetobacter infection[J].N Engl J Med,2008,358(12):1271-1281.
  • 10Falagas ME,Kasiakou SK,Rafailidis PI,et al.Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receivingappropriate and inappropriate empirical therapy[J].J Antimicrob Chemother,2006,57(6):1251-1254.

共引文献455

同被引文献94

引证文献9

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部